Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2016

Open Access 01-12-2016 | Research article

Usefulness of the SF-36 Health Survey in screening for depressive and anxiety disorders in rheumatoid arthritis

Authors: Faith Matcham, Sam Norton, Sophia Steer, Matthew Hotopf

Published in: BMC Musculoskeletal Disorders | Issue 1/2016

Login to get access

Abstract

Background

This study aimed to assess the accuracy of the Short-Form Health Survey (SF-36) mental health subscale (MH) and mental component summary (MCS) scores in identifying the presence of probable major depressive or anxiety disorder in patients with rheumatoid arthritis.

Methods

SF-36 data were collected in 100 hospital outpatients with rheumatoid arthritis. MH and MCS scores were compared against depression and anxiety data collected using validated measures as part of routine clinical practice. Sensitivity and specificity of the SF-36 were established using receiver operating characteristic (ROC) curve analysis, and area under the curve (AUC) compared the performance of the SF-36 components with the 9-item Patient Health Questionnaire (PHQ9) for depression and the 7-item Generalised Anxiety Disorder (GAD7) questionnaire for anxiety.

Results

The MH with a threshold of ≤52 had sensitivity and specificity of 81.0 and 71.4 % respectively to detect anxiety, correctly classifying 73.5 % of patients with probable anxiety disorder. A threshold of ≤56 had sensitivity and specificity of 92.6 and 73.2 % respectively to detect depression, correctly classifying 78.6 % of patients, and the same threshold could also be used to detect either depression or anxiety with a sensitivity of 87.9 %, specificity of 76.9 % and accuracy of 80.6 %. The MCS with a threshold of ≤35 had sensitivity and specificity of 85.7 and 81.9 % respectively to detect anxiety, correctly classifying 82.8 % of patients with probable anxiety disorder. A threshold of ≤40 had sensitivity and specificity of 92.3 and 70.2 % respectively to detect depression, correctly classifying 76.3 % of patients. A threshold of ≤38 could be used to detect either depression or anxiety with a sensitivity of 87.5 %, specificity of 80.3 % and accuracy of 82.8 %.

Conclusion

This analysis may increase the utility of a widely-used questionnaire. Overall, optimal use of the SF-36 for screening for mental disorder may be through using the MCS with a threshold of ≤38 to identify the presence of either depression or anxiety.
Appendix
Available only for authorised users
Literature
1.
go back to reference Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Norton S, et al. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Sem Arth Rheum. 2014;44:123–30.CrossRef Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Norton S, et al. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Sem Arth Rheum. 2014;44:123–30.CrossRef
2.
go back to reference Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology. 2013;52:2136–48.CrossRefPubMedPubMedCentral Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology. 2013;52:2136–48.CrossRefPubMedPubMedCentral
3.
go back to reference Spitzer RL. Utility of a new procedure for diagnosing mental disorders in primary care. JAMA. 1994;272:174–56.CrossRef Spitzer RL. Utility of a new procedure for diagnosing mental disorders in primary care. JAMA. 1994;272:174–56.CrossRef
4.
go back to reference Matcham F, Ali S, Hotopf M, Chalder T. Psychological correlates of fatigue in rheumatoid arthritis: a systematic review. Clin Psychol Rev. 2015;39:16–29.CrossRefPubMed Matcham F, Ali S, Hotopf M, Chalder T. Psychological correlates of fatigue in rheumatoid arthritis: a systematic review. Clin Psychol Rev. 2015;39:16–29.CrossRefPubMed
5.
go back to reference Matcham F, Norton S, Scott DL, Steer S, Hotopf M. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomised controlled trial. Rheumatology. 2016;55:268–78.CrossRefPubMedPubMedCentral Matcham F, Norton S, Scott DL, Steer S, Hotopf M. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomised controlled trial. Rheumatology. 2016;55:268–78.CrossRefPubMedPubMedCentral
6.
go back to reference Rathbun AM, Reed GQ, Harrold LR. The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review. Rheumatology. 2013;52:1785–94.CrossRefPubMed Rathbun AM, Reed GQ, Harrold LR. The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review. Rheumatology. 2013;52:1785–94.CrossRefPubMed
7.
go back to reference Kalyoncu U, Dougados M, Daurès J-P, Gossec L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2009;68:183–90.CrossRefPubMed Kalyoncu U, Dougados M, Daurès J-P, Gossec L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2009;68:183–90.CrossRefPubMed
8.
go back to reference Ware JEJ, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed Ware JEJ, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed
9.
go back to reference Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ. 1993;306:1440–4.CrossRefPubMedPubMedCentral Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ. 1993;306:1440–4.CrossRefPubMedPubMedCentral
10.
go back to reference Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol. 2003;30:167–78.PubMed Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol. 2003;30:167–78.PubMed
11.
go back to reference Rayner L, Matcham F, Hutton J, Stringer C, Dobson J, Steer S, et al. Embedding integrating mental health assessment in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder. Gen Hosp Psychiatr. 2014;36:318–24.CrossRef Rayner L, Matcham F, Hutton J, Stringer C, Dobson J, Steer S, et al. Embedding integrating mental health assessment in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder. Gen Hosp Psychiatr. 2014;36:318–24.CrossRef
12.
go back to reference Silveira E, Taft C, Sundh V, Waern M, Palsson S, Steen B. Performance of the SF-36 Health Survey in screening for depressive and anxiety disorders in an elderly female Swedish population. Qual Life Res. 2005;14:1263–74.CrossRefPubMed Silveira E, Taft C, Sundh V, Waern M, Palsson S, Steen B. Performance of the SF-36 Health Survey in screening for depressive and anxiety disorders in an elderly female Swedish population. Qual Life Res. 2005;14:1263–74.CrossRefPubMed
13.
go back to reference National Institute of Clinical Excellent (NICE). Depression in adults with a chronic physical health problem: Treatment and management. NICE Clinical Guidance 91. London: National Institute for Health and Clinical Excellence; 2015. National Institute of Clinical Excellent (NICE). Depression in adults with a chronic physical health problem: Treatment and management. NICE Clinical Guidance 91. London: National Institute for Health and Clinical Excellence; 2015.
14.
go back to reference Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord. 2004;78:131–40.CrossRefPubMed Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord. 2004;78:131–40.CrossRefPubMed
15.
go back to reference Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–7.CrossRefPubMed Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–7.CrossRefPubMed
16.
go back to reference National Institute of Clinical Excellent (NICE). Rheumatoid arthritis: The management of rheumatoid arthritis in adults. NICE Clinical Guidance 79. London: National Institute for Health and Clinical Excellence; 2009. National Institute of Clinical Excellent (NICE). Rheumatoid arthritis: The management of rheumatoid arthritis in adults. NICE Clinical Guidance 79. London: National Institute for Health and Clinical Excellence; 2009.
17.
go back to reference Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values. Ann Rheum Dis. 2007;66:407–9.CrossRefPubMedPubMedCentral Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values. Ann Rheum Dis. 2007;66:407–9.CrossRefPubMedPubMedCentral
18.
go back to reference Ware KE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: manual and interpretation guide. Boston: Health Institute, New England Medical Center; 1993. Ware KE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: manual and interpretation guide. Boston: Health Institute, New England Medical Center; 1993.
19.
20.
go back to reference Jaeschke R, Guyatt GH, Sackett DL, Guyatt G, Bass E, Brill-Edwards P, et al. Users’ guides to the medical literature. III. How to use an article about a diagnostic test B. What are the results and will they help me in caring for my patients? JAMA. 1994;271:703–7.CrossRefPubMed Jaeschke R, Guyatt GH, Sackett DL, Guyatt G, Bass E, Brill-Edwards P, et al. Users’ guides to the medical literature. III. How to use an article about a diagnostic test B. What are the results and will they help me in caring for my patients? JAMA. 1994;271:703–7.CrossRefPubMed
21.
go back to reference Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res. 2010;62:647–56.CrossRef Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res. 2010;62:647–56.CrossRef
Metadata
Title
Usefulness of the SF-36 Health Survey in screening for depressive and anxiety disorders in rheumatoid arthritis
Authors
Faith Matcham
Sam Norton
Sophia Steer
Matthew Hotopf
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2016
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-016-1083-y

Other articles of this Issue 1/2016

BMC Musculoskeletal Disorders 1/2016 Go to the issue